Biotech · Private company
Lycera Corp.
Track this companyFree. Adds Lycera Corp. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Drug: LYC-30937-ECPhase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- LYC-30937-ECPhase 2 · Colitis, UlcerativeClinicalTrials.gov · fetched Nov 12, 2026
- LYC-55716Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- LYC-55716Phase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung CancerPHASE1 · UNKNOWN · started Aug 3, 2018ClinicalTrials.gov NCT03396497 · fetched Nov 12, 2026
- An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type PsoriasisPHASE2 · COMPLETED · started Dec 5, 2016ClinicalTrials.gov NCT02872285 · fetched Nov 12, 2026
- Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic CancerPHASE1_PHASE2 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT02929862 · fetched Nov 12, 2026
- Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative ColitisPHASE2 · TERMINATED · started Nov 1, 2016ClinicalTrials.gov NCT02764229 · fetched Nov 12, 2026
- An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative ColitisPHASE2 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02762500 · fetched Nov 12, 2026